![]() | <img alt="" height="1" width="1" />DDW: Rifaximin Bests Placebo for Irritable Bowel SyndromeMedPage TodayNEW ORLEANS -- The antibiotic rifaximin (Xifaxan) met its primary endpoint in two phase III trials in nonconstipational irritable bowel syndrome (IBS), ...Behavioural therapy eases bowel troubles<nobr>NDTV.com</nobr>Cognitive Behavioral Therapy may Help IBS Patients<nobr>MedIndia (press release)</nobr>Bowel troubles finds help with Behavioral therapy<nobr>TopNews Singapore (press release)</nobr><nobr>Medscape</nobr> -<nobr>TopNews United States</nobr> -<nobr>EndoNurse</nobr><nobr>all 12 news articles »</nobr> |